Koers CaliPharms, Inc. Other OTC
Aandelen
KGET
US4984561021
Farmaceutische producten
Omzet 2012 | - | Omzet 2013 | - | Marktkapitalisatie | 8,23 mln. 7,59 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | - 0 | Nettowinst (verlies) 2013 | - 0 | EV/omzet 2012 * | - |
Nettoschuld 2012 | 617K 569K | Nettoschuld 2013 | 667K 615K | EV/omzet 2013 | - |
K/w-verhouding 2012 * |
-
| K/w-verhouding 2013 |
-0,51
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,29% | 6,02 mld. | |
-21,28% | 4,19 mld. | |
+4,52% | 3,25 mld. | |
-18,16% | 2,87 mld. | |
-7,70% | 2,37 mld. | |
+41,50% | 1,89 mld. | |
-4,05% | 1,58 mld. | |
-15,56% | 1,54 mld. | |
-14,62% | 1,5 mld. |